AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $307B
1-Year Return 24.17%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Quarter Return
-6.77%
1 Year Return
+24.17%
3 Year Return
+108.02%
5 Year Return
+184.14%
10 Year Return
+481.49%
AUM
$259B
AUM Growth
-$23.7B
Cap. Flow
+$1.57B
Cap. Flow %
0.61%
Top 10 Hldgs %
24.79%
Holding
3,384
New
99
Increased
1,504
Reduced
1,399
Closed
133

Sector Composition

1 Technology 26.03%
2 Healthcare 16.1%
3 Consumer Discretionary 12.27%
4 Financials 11.96%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PBYI icon
3026
Puma Biotechnology
PBYI
$253M
$161K ﹤0.01%
55,900
+100
+0.2% +$288
PHAT icon
3027
Phathom Pharmaceuticals
PHAT
$875M
$159K ﹤0.01%
11,700
-1,200
-9% -$16.3K
RVP icon
3028
Retractable Technologies
RVP
$23.7M
$159K ﹤0.01%
33,500
CRDO icon
3029
Credo Technology Group
CRDO
$24.4B
$157K ﹤0.01%
+10,300
New +$157K
NGMS
3030
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$156K ﹤0.01%
10,100
BV icon
3031
BrightView Holdings
BV
$1.36B
$155K ﹤0.01%
11,400
-115,790
-91% -$1.57M
VRCA icon
3032
Verrica Pharmaceuticals
VRCA
$48.2M
$155K ﹤0.01%
1,910
RYAM icon
3033
Rayonier Advanced Materials
RYAM
$397M
$154K ﹤0.01%
23,480
+92
+0.4% +$603
AEVA
3034
Aeva Technologies
AEVA
$786M
$153K ﹤0.01%
7,054
-2,307
-25% -$50K
ATRO icon
3035
Astronics
ATRO
$1.37B
$153K ﹤0.01%
11,800
-2,100
-15% -$27.2K
KALV icon
3036
KalVista Pharmaceuticals
KALV
$796M
$153K ﹤0.01%
10,400
-1,800
-15% -$26.5K
KLRS
3037
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
$151K ﹤0.01%
970
TIPT icon
3038
Tiptree Inc
TIPT
$849M
$150K ﹤0.01%
11,700
QTTB icon
3039
Q32 Bio
QTTB
$20.4M
$150K ﹤0.01%
2,733
+5
+0.2% +$274
TRHC
3040
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$149K ﹤0.01%
25,800
-70,296
-73% -$406K
CGEM icon
3041
Cullinan Oncology
CGEM
$413M
$148K ﹤0.01%
14,100
-1,800
-11% -$18.9K
PRLD icon
3042
Prelude Therapeutics
PRLD
$69.6M
$148K ﹤0.01%
21,500
-1,968
-8% -$13.5K
NEUE icon
3043
NeueHealth
NEUE
$60.3M
$148K ﹤0.01%
960
+816
+567% +$126K
LFAC
3044
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
$148K ﹤0.01%
+14,785
New +$148K
DNZ
3045
DELISTED
D and Z Media Acquisition Corp.
DNZ
$147K ﹤0.01%
15,000
ATOS icon
3046
Atossa Therapeutics
ATOS
$102M
$146K ﹤0.01%
116,500
+400
+0.3% +$501
GLRE icon
3047
Greenlight Captial
GLRE
$436M
$144K ﹤0.01%
20,305
ORMP icon
3048
Oramed Pharmaceuticals
ORMP
$91.4M
$144K ﹤0.01%
16,700
ZYXI icon
3049
Zynex
ZYXI
$45.1M
$144K ﹤0.01%
23,163
-36,416
-61% -$226K
ASXC
3050
DELISTED
Asensus Surgical, Inc.
ASXC
$142K ﹤0.01%
226,900
+700
+0.3% +$438